Literature DB >> 5096113

Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management.

M Martinez-Maldonado, J Yium, W N Suki, G Eknoyan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5096113     DOI: 10.1016/0021-9681(71)90076-2

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


× No keyword cloud information.
  8 in total

1.  Effect on renal function of an iso-osmolar contrast agent in patients with monoclonal gammopathies.

Authors:  Lorenzo Preda; Alberto Agazzi; Sara Raimondi; Carla Federica Lanfranchi; Rita Passerini; Albania Calvetta; Giovanni Martinelli; Massimo Bellomi
Journal:  Eur Radiol       Date:  2010-08-02       Impact factor: 5.315

2.  Maintenance hemodialysis in myeloma kidney disease.

Authors:  N D Vaziri; R Goldman; R G Schultze; D B Lee; S M Rosen
Journal:  West J Med       Date:  1977-02

3.  The kidney in multiple myeloma.

Authors: 
Journal:  West J Med       Date:  1978-07

4.  Multiple myeloma presenting as recurrent ureteric obstruction.

Authors:  J Weir; F A Schweitzer
Journal:  J R Soc Med       Date:  1996-12       Impact factor: 18.000

5.  Amyloid casts within renal tubules: a singular finding in myelomatosis.

Authors:  M Melato; G Falconieri; E Pascali; A Pezzoli
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

6.  Pathogenic potential of human monoclonal immunoglobulin light chains: relationship of in vitro aggregation to in vivo organ deposition.

Authors:  E A Myatt; F A Westholm; D T Weiss; A Solomon; M Schiffer; F J Stevens
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  Spectrum of monoclonal gammapathies in Andhra Pradesh.

Authors:  T Malati; B Yadagiri; D M Krishna; V Shantaram; D Raghunadharao; K Subbarao
Journal:  Indian J Clin Biochem       Date:  2001-01

8.  Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial.

Authors:  E H Cooper; M A Forbes; R A Crockson; I C MacLennan
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.